Product NDC: | 68682-995 |
Proprietary Name: | Acyclovir |
Non Proprietary Name: | acyclovir |
Active Ingredient(s): | 50 mg/g & nbsp; acyclovir |
Administration Route(s): | TOPICAL |
Dosage Form(s): | OINTMENT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68682-995 |
Labeler Name: | Oceanside Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018604 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20121003 |
Package NDC: | 68682-995-95 |
Package Description: | 1 TUBE in 1 CARTON (68682-995-95) > 30 g in 1 TUBE |
NDC Code | 68682-995-95 |
Proprietary Name | Acyclovir |
Package Description | 1 TUBE in 1 CARTON (68682-995-95) > 30 g in 1 TUBE |
Product NDC | 68682-995 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | acyclovir |
Dosage Form Name | OINTMENT |
Route Name | TOPICAL |
Start Marketing Date | 20121003 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Oceanside Pharmaceuticals |
Substance Name | ACYCLOVIR |
Strength Number | 50 |
Strength Unit | mg/g |
Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |